Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FA4EE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,113
Award facts
- Contract value 100% obligated
- $10,113.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,113.12 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and a completion deadline of September 25, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters and primary distribution center. RINVOQ ER is a targeted immunosuppressant medication used for inflammatory conditions, representing part of the company's extensive pharmaceutical supply portfolio to support federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's position as a primary pharmaceutical vendor reflects the company's established capability to meet federal procurement requirements across therapeutic domains through competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DB25FA4EE?
SPE2DB25FA4EE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FA4EE worth?
The government has obligated $10,113 on SPE2DB25FA4EE.
Is contract SPE2DB25FA4EE an order under another contract?
Yes. SPE2DB25FA4EE is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FA4EE competed?
The extent of competition for SPE2DB25FA4EE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award